Qi Ling Decreases Paclitaxel Resistance in the Human Prostate Cancer by Reversing Tumor-Associated Macrophages Function

Investigators administrated Qi Ling (QL) to rats and collected the serum from QL-treated rats and established the co-culture system of tumor-associated macrophages/paclitaxel resistant prostate cancer cells.